EASTPHARMA LTD.
London, 30 April 2014 - EastPharma (EAST LI), a company active in the manufacturing and marketing of pharmaceutical products in Turkey and in other regional markets, informs that it will be announcing its Q1 2014 sales performance and a review of its main subsidiary DEVA Holding's financial statements for the related period on 12 May 2014.
A conference call to review the Q1 2014 sales performance will be hosted by the management of EastPharma at 4:00pm London time on 13 May 2014 (11:00am New York / 5:00pm Zurich time / 6:00pm Istanbul time). The dial-in details are provided below.
Conference call:
Participant Std International Dial-In:
United Kingdom: +44 (0) 14 5255 5566
United States: +1 631 510 7498
Participant Local Dial-In:
Switzerland, Baden: 0565800007
Germany, Frankfurt: 06922224918
Conference ID: 40395638
For further information, please contact:
Investor Relations:
email: ir@eastpharmaltd.com